DE60233674D1 - Glykosylphosphatidylinositolhaltige polypeptide - Google Patents

Glykosylphosphatidylinositolhaltige polypeptide

Info

Publication number
DE60233674D1
DE60233674D1 DE60233674T DE60233674T DE60233674D1 DE 60233674 D1 DE60233674 D1 DE 60233674D1 DE 60233674 T DE60233674 T DE 60233674T DE 60233674 T DE60233674 T DE 60233674T DE 60233674 D1 DE60233674 D1 DE 60233674D1
Authority
DE
Germany
Prior art keywords
polypeptides
holding
glycosyl phosphatidylinositol
relates
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233674T
Other languages
English (en)
Inventor
Richard Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asterion Ltd
Original Assignee
Asterion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0124620A external-priority patent/GB2380735A/en
Priority claimed from GB0200904A external-priority patent/GB0200904D0/en
Priority claimed from GB0218889A external-priority patent/GB0218889D0/en
Application filed by Asterion Ltd filed Critical Asterion Ltd
Application granted granted Critical
Publication of DE60233674D1 publication Critical patent/DE60233674D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
DE60233674T 2001-10-13 2002-10-11 Glykosylphosphatidylinositolhaltige polypeptide Expired - Lifetime DE60233674D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0124620A GB2380735A (en) 2001-10-13 2001-10-13 GPI-anchored proteins
GB0200904A GB0200904D0 (en) 2002-01-16 2002-01-16 Anchors-2
GB0218889A GB0218889D0 (en) 2002-08-14 2002-08-14 Anchors 3
PCT/GB2002/004665 WO2003034275A2 (en) 2001-10-13 2002-10-11 Chimeric glycosylphosphatidylinositol containing peptides

Publications (1)

Publication Number Publication Date
DE60233674D1 true DE60233674D1 (de) 2009-10-22

Family

ID=27256298

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233674T Expired - Lifetime DE60233674D1 (de) 2001-10-13 2002-10-11 Glykosylphosphatidylinositolhaltige polypeptide

Country Status (17)

Country Link
US (1) US7485713B2 (de)
EP (1) EP1446733B1 (de)
JP (1) JP4384492B2 (de)
KR (2) KR20050035511A (de)
CN (1) CN1568330A (de)
AT (1) ATE442444T1 (de)
AU (1) AU2002334161B2 (de)
CA (1) CA2494706A1 (de)
DE (1) DE60233674D1 (de)
DK (1) DK1446733T3 (de)
ES (1) ES2329228T3 (de)
HU (1) HUP0401611A3 (de)
IL (1) IL161296A0 (de)
NZ (1) NZ532460A (de)
PL (1) PL369953A1 (de)
PT (1) PT1446733E (de)
WO (1) WO2003034275A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790655B2 (en) 2005-10-14 2010-09-07 Medimmune, Llc Cell display of antibody libraries
US8084585B2 (en) * 2005-12-20 2011-12-27 Sbi Biotech Co., Ltd. Anti-ILT7 antibody
WO2007098547A1 (en) * 2006-03-01 2007-09-07 Apollo Life Sciences Limited A molecule and chimeric molecules thereof
GB0618082D0 (en) * 2006-09-14 2006-10-25 Asterion Ltd Growth factor
EP2068914A4 (de) * 2007-02-09 2011-07-20 Medimmune Llc Antikörperbibliothekdisplay durch hefezellplasmamembrane
NZ602170A (en) * 2008-02-08 2014-03-28 Ambrx Inc Modified leptin polypeptides and their uses
EP3335721A1 (de) 2013-04-12 2018-06-20 Evox Therapeutics Limited Vesikel zur abgabe von therapeutika

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US4857637A (en) * 1986-05-07 1989-08-15 Genentech, Inc. Methods and compositions for immunologically modulating growth hormone receptor activity
US5057417A (en) * 1987-06-12 1991-10-15 Genentech, Inc. Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
US6113917A (en) * 1995-04-25 2000-09-05 Rmf Dictagene S.A. Modified polypeptides for enhanced immunogenicity
TW562807B (en) 1997-04-01 2003-11-21 Chugai Pharmaceutical Co Ltd Novel secretory membrane protein
WO1999000423A1 (en) * 1997-06-26 1999-01-07 Immunex Corporation Protein that binds trail
JP3471006B2 (ja) * 1998-05-20 2003-11-25 中外製薬株式会社 新規な遺伝子クローニング方法
EP1171579A4 (de) 1999-03-24 2002-07-31 Human Genome Sciences Inc Humaner tumormekrosefaktorrezeptor tr9
JP3815409B2 (ja) * 2002-08-29 2006-08-30 ブラザー工業株式会社 電話端末、通話システムおよび端末制御プログラム

Also Published As

Publication number Publication date
CA2494706A1 (en) 2003-04-24
IL161296A0 (en) 2004-09-27
PL369953A1 (en) 2005-05-02
JP4384492B2 (ja) 2009-12-16
WO2003034275A3 (en) 2003-11-27
JP2005505307A (ja) 2005-02-24
PT1446733E (pt) 2009-09-28
EP1446733B1 (de) 2009-09-09
WO2003034275A2 (en) 2003-04-24
KR20050035511A (ko) 2005-04-18
ES2329228T3 (es) 2009-11-24
DK1446733T3 (da) 2009-10-26
EP1446733A2 (de) 2004-08-18
ATE442444T1 (de) 2009-09-15
US7485713B2 (en) 2009-02-03
KR20100039911A (ko) 2010-04-16
HUP0401611A3 (en) 2010-01-28
CN1568330A (zh) 2005-01-19
US20050059577A1 (en) 2005-03-17
AU2002334161B2 (en) 2007-03-29
HUP0401611A2 (hu) 2004-11-29
NZ532460A (en) 2005-10-28

Similar Documents

Publication Publication Date Title
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
WO2006083301A3 (en) Immunogenic compositions comprising hmgb1 polypeptides
CY1112101T1 (el) Νευροτροφικοι παραγοντες
ATE533845T1 (de) Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken
DK1229047T3 (da) IL-1-receptor-fusionsproteiner anvendt som antagonister og fremgangsmåder til fremstilling og anvendelse
TR200102191T2 (tr) HER-2/neu füzyon proteinleri.
EA200301158A1 (ru) Антитела, блокирующие cripto, и их применения
DK1482041T3 (da) NL6-TIE-receptor-tyrosinkinase-ligand-homolog
IS2786B (is) Prótín sem bindast viðtaka Nogo
DK1287130T3 (da) Cytokinreceptorunderenhedproteiner fra pattedyr, tilhörende reagenser og fremgangsmåder
ATE342976T1 (de) Cytokinrezeptor-kette
EP2292760A3 (de) Säuger Zytokine, Receptoren, verwandte Reagentien und Methoden
DE60233674D1 (de) Glykosylphosphatidylinositolhaltige polypeptide
ATE390482T1 (de) Interleukin-1 hy2. mittel und verfahren
DE60133366D1 (de) Irak-4 zusammensetzungen und deren verwendungen
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
TR200102655T2 (tr) Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen.
EP2270164A3 (de) Rekombinante Protein-Varianten
WO2002008257A3 (en) Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
WO2003018756A3 (en) Methods for preparing purified prostaglandin e synthase
IL162601A0 (en) Raf/ras binding proteins, their preparation and use
NO20051938L (no) Promoter til IL-18BP, dens fremstilling og anvendelse
ATE443715T1 (de) Polypeptide aus haemophilus influenza
ATE325873T1 (de) Androgenrezeptor-komplex assoziiertes protein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition